
Targeting the metabolic reprogramming associated with cdk4/6 inhibition as an effective combined therapy in colon cancer
Targeting the metabolic reprogramming associated with cdk4/6 inhibition as an effective combined therapy in colon cancer https://www.metabolism-cancer.com/wp-content/uploads/2021/05/Tarrado-Castellarnau_page-0001.jpg 1241 1755 Metabolism & Cancer //www.metabolism-cancer.com/wp-content/uploads/2022/12/MEtabo2023-logo.png
You must belogged in to post a comment.